Cancer Research and Treatment

Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion

Bao Zhang, Shenghan Wang, Zhichao Fu, Qiang Gao, Lin Yang, Zhentao Lei, Yuqiang Shi, Kai Le, Jie Xiong, Siyao Liu, Jiali Zhang, Junyan Su, Jing Chen, Mengyuan Liu, Beifang Niu

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer

Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?

Clara Martori, Lidia Sanchez-Moral, Tony Paul, Juan Carlos Pardo, Albert Font, Vicenç Ruiz de Porras, Maria-Rosa Sarrias

Plasma Chemokine C-C Motif Ligand 2 as a Potential Biomarker for Prostate Cancer

Martin Lund, Torben B Pedersen, Søren Feddersen, Louise D Østergaard, Charlotte A Poulsen, Christian Enggaard, Mads H Poulsen, Lars Lund

Research and Reports in Urology.2022; Volume 14: 33. CrossRef

Potential PET tracers for imaging of tumor-associated macrophages

Bruna Fernandes, Paula Kopschina Feltes, Carolina Luft, Luiza Reali Nazario, Cristina Maria Moriguchi Jeckel, Ines F. Antunes, Philip H. Elsinga, Erik F. J. de Vries

EJNMMI Radiopharmacy and Chemistry.2022;[Epub] CrossRef

Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study

Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami

Japanese Journal of Clinical Oncology.2022;[Epub] CrossRef

Potential mechanisms ofPyrrosiae Foliumin treating prostate cancer based on network pharmacology and molecular docking

Drug Development and Industrial Pharmacy.2022; 48(5): 189. CrossRef

White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions

Cancer and Metastasis Reviews.2022; 41(3): 649. CrossRef

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer

Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifu

Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?

International Journal of Molecular Sciences.2021; 22(3): 1500. CrossRef

Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients

Mónica Macías, Ángel García-Cortés, Marcos Torres, Javier Ancizu-Marckert, Juan Ignacio Pascual, Fernando Díez-Caballero, José Enrique Robles, David Rosell, Bernardino Miñana, Beatriz Mateos, Daniel Ajona, Rodrigo Sánchez-Bayona, Oihane Bedialauneta, Susa

Research Trends and Regulation of CCL5 in Prostate Cancer

Renlun Huang, Lang Guo, Menghan Gao, Jing Li, Songtao Xiang

OncoTargets and Therapy.2021; Volume 14: 1417. CrossRef

Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression

Wei Bin Fang, Diana Sofia Acevedo, Curtis Smart, Brandon Zinda, Nadia Alissa, Kyle Warren, Garth Fraga, Li-Ching Huang, Yu Shyr, Wei Li, Lu Xie, Vincent Staggs, Yan Hong, Fariba Behbod, Nikki Cheng

CCL2 (C-C Motif Chemokine Ligand 2) Biomarker Responses in Central Versus Peripheral Compartments After Focal Cerebral Ischemia

Jingfei Shi, Wenlu Li, Fang Zhang, Ji Hyun Park, Hong An, Shuzhen Guo, Yunxia Duan, Di Wu, Kazuhide Hayakawa, Eng H. Lo, Xunming Ji

On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances

Yiwu Yan, Su Yeon Yeon, Chen Qian, Sungyong You, Wei Yang

International Journal of Molecular Sciences.2021; 22(24): 13537. CrossRef

Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting

Tetiana Hourani, James A. Holden, Wenyi Li, Jason C. Lenzo, Sara Hadjigol, Neil M. O’Brien-Simpson

Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?

Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study

Xiaohui Sun, Ding Ye, Lingbin Du, Yu Qian, Xia Jiang, Yingying Mao

International Journal of Cancer.2020; 147(9): 2469. CrossRef

SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer

Jungsug Gwak, Hayan Jeong, Kwanghyun Lee, Jee Yoon Shin, Taejun Sim, Jungtae Na, Jongchan Kim, Bong-Gun Ju

The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative

Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?

Natalia Rybtsova, Tatiana Berezina, Alexander Kagansky, Stanislav Rybtsov

Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine

Orazio Schillaci, Manuel Scimeca, Donata Trivigno, Agostino Chiaravalloti, Simone Facchetti, Lucia Anemona, Rita Bonfiglio, Giuseppe Santeusanio, Virginia Tancredi, Elena Bonanno, Nicoletta Urbano, Alessandro Mauriello

Nuclear Medicine and Biology.2019; 68-69: 66. CrossRef

Role of ALDH1A1 and HTRA2 expression to CCL2/CCR2 mediated breast cancer cell growth and invasion

Qingting Hu, Megan Myers, Wei Fang, Min Yao, Gage Brummer, Justin Hawj, Curtis Smart, Cory Berkland, Nikki Cheng

Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients

Takumi Kishimoto, Nobukazu Fujimoto, Takeshi Ebara, Toyonori Omori, Tetsuya Oguri, Akio Niimi, Takako Yokoyama, Munehiro Kato, Ikuji Usami, Masayuki Nishio, Kosho Yoshikawa, Takeshi Tokuyama, Mouka Tamura, Yoshifumi Yokoyama, Ken Tsuboi, Yoichi Matsuo, Ji

RETRACTED: Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment

Xiaolei Pei, Danfeng Zheng, Shaoping She, Zhiwei Fang, Shiying Zhang, Hao Hu, Kexin Xu, Ying Wang

More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis

Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features

Catarina Ferreira, João Lobo, Luís Antunes, Paula Lopes, Carmen Jerónimo, Rui Henrique

Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes

Jaroslaw Szczyrba, Volker Jung, Michaela Beitzinger, Elke Nolte, Sven Wach, Martin Hart, Sandra Sapich, Marc Wiesehöfer, Helge Taubert, Gunther Wennemuth, Norbert Eichner, Thomas Stempfl, Bernd Wullich, Gunter Meister, Friedrich A. Grässer

Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients

Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Alan Forrest, Alice C. Ceacareanu

Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer

Zachary A.P. Wintrob, Jeffrey P. Hammel, George K. Nimako, Zahra S. Fayazi, Dan P. Gaile, Erin E. Davis, Alan Forrest, Alice C. Ceacareanu

Activity and Functions of Tumor-associated Macrophages in Prostate Carcinogenesis

Matteo Santoni, Liang Cheng, Alessandro Conti, Cinzia Mariani, Antonio Lopez-Beltran, Rodolfo Montironi, Nicola Battelli

European Urology Supplements.2017; 16(12): 301. CrossRef

Association of mast cell infiltration with gastric cancer progression

Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer

Tomomi Fujii, Keiji Shimada, Yoshihiro Tatsumi, Nobumichi Tanaka, Kiyohide Fujimoto, Noboru Konishi

Molecular Carcinogenesis.2016; 55(9): 1378. CrossRef

Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review

Alessandro Sciarra, Alessandro Gentilucci, Stefano Salciccia, Federico Pierella, Flavio Del Bianco, Vincenzo Gentile, Ida Silvestri, Susanna Cattarino

Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model

Stefano Garetto, Claudia Sardi, Elisa Martini, Giuliana Roselli, Diego Morone, Roberta Angioni, Beatrice Claudia Cianciotti, Anna Elisa Trovato, Davide Giuseppe Franchina, Giovanni Francesco Castino, Debora Vignali, Marco Erreni, Federica Marchesi, Cristi

Inflammation and prostate cancer: friends or foe?

Gianluigi Taverna, Elisa Pedretti, Giuseppe Di Caro, Elena Monica Borroni, Federica Marchesi, Fabio Grizzi

CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro

Igor Tsaur, Jochen Rutz, Jasmina Makarević, Eva Juengel, Kilian M. Gust, Hendrik Borgmann, David Schilling, Karen Nelson, Axel Haferkamp, Georg Bartsch, Roman A. Blaheta

World Journal of Urology.2015; 33(7): 1051. CrossRef

sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients

Igor Tsaur, Kristina Thurn, Eva Juengel, Kilian M. Gust, Hendrik Borgmann, Rene Mager, Georg Bartsch, Elsie Oppermann, Hanns Ackermann, Karen Nelson, Axel Haferkamp, Roman A. Blaheta

Journal of Experimental & Clinical Cancer Research.2015;[Epub] CrossRef

The Role of Biomarkers and Genetics in the Diagnosis of Prostate Cancer

Firas Abdollah, Deepansh Dalela, Michael C. Haffner, Zoran Culig, Jack Schalken